DYMDF:OTCMKTS
Diamyd Medical AB
$0.73
0.00%
(0.00) 1D
Apr 14, 2:48:13 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DYMDF...
Mkt. cap
148.00M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
Mkt. cap
148.00M
Volume
0.00
52-wk high
$0.73
52-wk low
$0.73
Shares outstanding
134.00M
No. of employees
42
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
The Motley Fool
·
3 hours ago
No Matter What Happens to the S&P 500 in November, These 3 Dividend Stocks Belong in Your Portfolio
BigGo Finance
·
15 hours ago
Global AI and Semiconductor Stocks Plunge; S&P 500 Tumbles 4.4% in a Single Day as Markets Watch Whether Three Central Banks Will Raise Rates in December
Exchange Rates UK
·
41 minutes ago
S&P 500 Slide Exposes Large Stock Moves Hidden Beneath The Index
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees42
Founded1984
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitediamyd.com